NAV

Pomegranate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Pomegranate
Accession Number
DB14317
Description

Pomegranate is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental, Investigational
Synonyms
  • Ae-pomegrante
  • Allergenic Extract- Pomegranate Punica Granatum
  • Dadima Fruit
  • Pomegranate Extract
  • Pomegranate Fruit
  • Pomegranate Fruit Polyphenol Extract
  • Pomegranates, Raw
  • Pomegranates,raw
  • Punica Granatum Fruit
  • Punica Granatum Fruit Extract
  • Shi Liu Fruit

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Unlock Additional Data
Red CleoJelly44.335 g/100gOralHLscience Co Ltd2016-04-052018-02-12US flag
Red CleoLiquid1 mg/1mLTopicalHealth-Love Co.2013-07-022017-01-01US flag
Additional Data Available
  • Application Number
    Application Number
    Available for Purchase

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code
    Available for Purchase

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Frudia Pomegranate Nutri Moisturizing MaskPomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL)PatchTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing SerumPomegranate (31.99 g/50g) + Adenosine (0.02 g/50g)CreamTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing TonerPomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL)LiquidTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Frudia Pomegranate Nutri Moisturizing MaskPomegranate (12.57 g/27mL) + Adenosine (0.01 g/27mL)PatchTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing SerumPomegranate (31.99 g/50g) + Adenosine (0.02 g/50g)CreamTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Frudia Pomegranate Nutri Moisturizing TonerPomegranate (170.7 g/195mL) + Adenosine (0.07 g/195mL)LiquidTopicalWelcos Co.,ltd.2016-10-10Not applicableUS flag
Red CleoPomegranate (1 mg/1mL)LiquidTopicalHealth-Love Co.2013-07-022017-01-01US flag
Red CleoPomegranate (44.335 g/100g)JellyOralHLscience Co Ltd2016-04-052018-02-12US flag

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
56687D1Z4D
CAS number
Not Available

References

General References
Not Available
RxNav
1246101
Wikipedia
Pomegranate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentOral Lichen Planus1
2CompletedPreventionPSA Level Less Than or Equal to Fifteen / PSA Level Less Than Ten / Stage I Prostate Cancer AJCC v7 / Stage II Prostate Cancer AJCC v7 / Stage IIA Prostate Cancer AJCC v7 / Stage IIB Prostate Cancer AJCC v71
2RecruitingTreatmentMetabolic Syndromes1
2TerminatedTreatmentCardiomyopathy / Heart Failure1
2Unknown StatusTreatmentFollicular Lymphoma (FL)1
1RecruitingTreatmentSkin and Subcutaneous Tissue Disorders1
1Unknown StatusTreatmentBenign Prostatic Hyperplasia (BPH)1
Not AvailableCompletedPreventionGingivitis1
Not AvailableCompletedTreatmentProstate Cancer1
Not AvailableUnknown StatusTreatmentAtherosclerosis / Diabetes Mellitus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
PatchTopical
CreamTopical
LiquidTopical
JellyOral44.335 g/100g
LiquidTopical1 mg/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 11:13 / Updated on June 12, 2020 10:53